• Mubritinib Enhances Cisplatin Efficacy in NSCLC via Mitochon

  2026-06-29

  The referenced study demonstrates that Mubritinib (TAK 165), a mitochondrial complex I inhibitor, significantly enhances cisplatin's antitumor effects against non-small cell lung cancer (NSCLC) by increasing oxidative stress and apoptosis. This work highlights the potential of targeting mitochondrial function to overcome cisplatin resistance and provides a mechanistic basis for combination therapies in lung cancer.

• Naloxone Hydrochloride: Optimizing Opioid Receptor Antagonis

  2026-06-29

  Naloxone hydrochloride enables reproducible, high-impact opioid receptor antagonist workflows—spanning neural stem cell, immune modulation, and behavioral studies. This article delivers actionable protocols, troubleshooting strategies, and evidence-based insights to maximize experimental rigor with APExBIO’s high-purity compound.

• Rapakinin-Induced Vasorelaxation: Mechanisms in Hypertensive

  2026-06-28

  This study uncovers that rapakinin, a rapeseed-derived peptide, induces vasorelaxation in hypertensive rat mesenteric arteries via a prostaglandin I2 (PGI2)-IP receptor pathway, followed by activation of the CCK1 receptor. These findings highlight a distinct, nitric oxide-independent mechanism for blood pressure modulation, expanding the therapeutic landscape for vascular dysfunction.

• Restoring PTEN Function: mRNA Strategies for Overcoming Drug

  2026-06-27

  This article explores the mechanistic, translational, and strategic dimensions of leveraging in vitro transcribed mRNA—specifically, EZ Cap™ Human PTEN mRNA (ψUTP)—to address PI3K/Akt pathway-driven drug resistance in cancer. Integrating mechanistic insights, experimental validation, and workflow-focused guidance, it provides translational researchers with a roadmap for employing advanced mRNA tools to surmount longstanding barriers in oncology research.

• Light-Inducible RNA-Releasing Proteins for Gene Therapy Cont

  2026-06-26

  A recent study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that enables rapid, reversible control of therapeutic gene expression in vivo. This innovation advances translational regulation and optogenetic gene therapy, offering spatiotemporal precision and enhanced safety for treating chronic and retinal diseases.

• Bsa I (RNase-free): Technical Guide for Precise DNA Manipula

  2026-06-26

  Bsa I (RNase-free) addresses the need for precise DNA cleavage in molecular biology workflows where RNA integrity is essential, such as gene cloning and recombinant DNA technology. It should only be used in research settings requiring RNase-free conditions and is not suitable for diagnostic or clinical applications.

• Obeticholic Acid: FXR Agonist for Liver Fibrosis Research

  2026-06-25

  Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid) is a potent and selective FXR agonist used to modulate bile acid homeostasis and study liver fibrosis. Its robust activity in both in vitro and in vivo models supports its role in hepatic inflammation and portal hypertension research. APExBIO supplies this compound as B4888, enabling advanced translational studies.

• Ciprofloxacin in Research: Advanced Workflows and Real-World

  2026-06-25

  Ciprofloxacin, a benchmark fluoroquinolone antibiotic, is unlocking new experimental strategies in antimicrobial resistance research and beyond. This article dissects the latest workflow innovations, troubleshooting tips, and protocol controls for maximizing reproducible results with APExBIO's high-purity Ciprofloxacin.

• 25HC-Driven AMPK Activation Shapes Immunosuppressive Macroph

  2026-06-24

  Xiao et al. (2024) uncover how 25-hydroxycholesterol (25HC) accumulates in tumor-associated macrophages, activating AMPKα via a lysosomal GPR155-mTORC1 pathway and reprogramming their immunosuppressive function. These findings reveal CH25H as a metabolic checkpoint, reshaping tumor immunity and suggesting new strategies for targeting TAMs in cancer.

• TMEM16F-Mediated Lipid Scrambling Suppresses Ferroptosis in

  2026-06-23

  Yang et al. (2025) identify TMEM16F-mediated lipid scrambling as a critical suppressor of ferroptosis, revealing how plasma membrane remodeling limits cell death and promotes tumor immune rejection. This mechanistic insight bridges membrane biology and immunotherapy, offering new directions for cancer research.

• BH3 Mimetics Target Chemotherapy-Induced Senescence in Breas

  2026-06-23

  This study demonstrates that BH3 mimetics can selectively eliminate senescent tumor cells that persist after chemotherapy in TP53 wild-type breast cancer. The findings highlight a mechanistic vulnerability in senescent cancer cells and suggest that targeting anti-apoptotic proteins, including MCL1, may significantly improve therapeutic outcomes.

• Staurosporine in Translational Tumor Research: Beyond Apopto

  2026-06-22

  Explore the multifaceted role of Staurosporine as a broad-spectrum serine/threonine protein kinase inhibitor in translational cancer research. This cornerstone article uniquely bridges mechanistic insights with practical assay design, emphasizing anti-angiogenic applications and protocol optimization.

• 3D Electrophysiology in Cardiac Organoids with Shell MEAs

  2026-06-22

  This study introduces programmable shell microelectrode arrays (MEAs) for comprehensive 3D mapping of electrical activity in human cardiac organoids. The platform addresses longstanding limitations of 2D and destructive techniques, enabling high-resolution spatiotemporal analysis and pharmacological screening—advancing cardiac disease modeling and safety research.

• GSK621: Advanced Strategies for AMPK Agonist Use in AML Rese

  2026-06-21

  Explore how GSK621, a potent AMPK agonist, unlocks new capabilities in acute myeloid leukemia research. This article offers an in-depth, evidence-driven analysis of GSK621’s mechanism, protocol nuances, and unique experimental advantages.

• Hydroxyl Radical Degradation Mechanisms of Dimetridazole in

  2026-06-20

  This study delivers a quantum chemical analysis of how hydroxyl radicals degrade Dimetridazole (1,2-dimethyl-5-nitroimidazole) in aqueous environments. It elucidates detailed reaction pathways, kinetic parameters, and the toxicity evolution of intermediates, informing environmental risk and advanced oxidation process design.

7750 records 10/517 page Previous Next First page 上5页 678910 下5页 Last page